TY  - GEN
AU  - Furst,Daniel E
AU  - Kolba,Karen S
AU  - Fleischmann,Roy
AU  - Silverfield,Joel
AU  - Greenwald,Maria
AU  - Roth,Sanford
AU  - Hall,David B
AU  - Roszko,Paul J
TI  - Dose response and safety study of meloxicam up to 22.5 mg daily in rheumatoid arthritis: a 12 week multicenter, double blind, dose response study versus placebo and diclofenac
SN  - 0315-162X
PY  - 2002///0924
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Arthritis, Rheumatoid
KW  - drug therapy
KW  - Cyclooxygenase 2
KW  - Cyclooxygenase 2 Inhibitors
KW  - Cyclooxygenase Inhibitors
KW  - administration & dosage
KW  - Diclofenac
KW  - Double-Blind Method
KW  - Female
KW  - Humans
KW  - Isoenzymes
KW  - antagonists & inhibitors
KW  - Liver Function Tests
KW  - Male
KW  - Meloxicam
KW  - Membrane Proteins
KW  - Middle Aged
KW  - Placebos
KW  - Prostaglandin-Endoperoxide Synthases
KW  - Thiazines
KW  - Thiazoles
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
ER  -